Highlander Health Announces Inaugural Investment of Target RWE
Summary
Target RWE is a longitudinal data company that generates high-quality real-world datasets and evidence across multiple therapeutic areas, with liver disease as a flagship. launched Highlander Health Partners in September of 2024 to invest in companies and technology crucial to personalized care for all, and Target RWE marks their first acquisition. Target RWE’s data platform and key opinion leader network set an industry standard in real-world evidence and provide a ready-built framework for prospective clinical trials. Highlander Health is on a mission to modernize clinical research and care — toward flexible approaches, unlocked capacity, and faster and greater patient impact. Highlander Health Institute is an all-stakeholder platform that creates transparent answers on how best to update clinical evidence generation approaches to assure safe, effective and accessible treatments.